BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/03/2013

FDA Clears GEREF (Sermorelin Acetate) for Approval

The FDA has determined that two formulations of GEREF (Sermorelin Acetate) injection were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →